ARTG Entry
DESVENLAFAXINE VIATRIS
ARTG entry for DESVENLAFAXINE VIATRIS (desvenlafaxine 100 mg), ARTG 439470 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Alphapharm
- Active ingredient: desvenlafaxine 100 mg
- Therapeutic area: Psychiatry
What it is
DESVENLAFAXINE is an extended release tablet containing desvenlafaxine (as benzoate). The product is available in 50 mg and 100 mg strengths.
Regulatory history
DESVENLAFAXINE was first registered on the ARTG on 12 November 2014. ---
**Note:** The provided source document contains limited information. A complete Brand Dossier would typically include approved indications, dosing overview, key safety warnings, contraindications, and PBS listing details. These sections cannot be populated without additional source documentation.